Find Resources
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
This article conducts a retrospective case-control study of electronic health records of individuals who were diagnosed with COVID-19 and have a recent diagnosis of substance use disorder (SUD). The results show that those diagnosed with SUD, particularly African Americans and those with opioid use disorder (OUD), are more likely to contract COVID-19, as well as suffer worsening outcomes such as hospitalization and mortality due to COVID-19. This article shows that an increase in SUD screening could be a factor in mitigating the spread of COVID-19 in this community.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
This study looks at COVID-19 ICU admission, hospitalization, and mortality rates for patients with schizophrenia in France. From February to June 2020, the study team analyzed patient data and compared those experiencing schizophrenia to those without severe mental illness. Results showed that those with schizophrenia are more likely to be admitted to the ICU and hospital and, ultimately, have an increased mortality rate than their control group. This disparity is more prevalent with age, as people older than 65 have a significantly higher rate of mortality.